Evidence map›Paper›PMID 35451972›Full record

ArticleJMIR research protocols2022

Acceptability and Feasibility of a Return-to-Work Intervention for Posttreatment Breast Cancer Survivors: Protocol for a Co-design and Development Study.

Karine Bilodeau, Marie-Michelle Gouin, Alexandra Lecours, Valérie Lederer, Marie-José Durand, Kelley Kilpatrick, David Lepage, Lauriane Ladouceur-Deslauriers, Tomas Dorta

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Karine BilodeauFaculty of Nursing, University of Montreal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-0705-3426
Marie-Michelle GouinFaculté de médecine et des sciences de la santé, University of Sherbrooke, Longueuil, QC, Canada.ORCID https://orcid.org/0000-0002-6534-4897
Alexandra LecoursDépartement de relations industrielles, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada.ORCID https://orcid.org/0000-0002-4485-7829
Valérie LedererDépartement de relations industrielles, Université du Québec en Outaouais, Gatineau, QC, Canada.ORCID https://orcid.org/0000-0002-1841-1380
Marie-José DurandFaculté de médecine et des sciences de la santé, University of Sherbrooke, Longueuil, QC, Canada.ORCID https://orcid.org/0000-0002-4443-9387
Kelley KilpatrickCentre de recherche Hopital Maisonneuve Rosemont, Montreal, QC, Canada.ORCID https://orcid.org/0000-0003-2137-6560
David LepageCentre intégré universitaire de santé et de services sociaux de l'Est de l'île de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0002-6489-9276
Lauriane Ladouceur-DeslauriersCentre intégré universitaire de santé et de services sociaux de l'Est de l'île de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0001-8078-5722
Tomas DortaFaculté de l'aménagement, École de Design, Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0002-3312-9770
Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CAHôpital Maisonneuve-Rosemont · CAUniversité de Sherbrooke · CAUniversité de Montréal · CAUniversité du Québec à Trois-Rivières · CAUniversité du Québec en Outaouais · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mortality rate from breast cancer has been declining for many years, and the population size of working-age survivors is steadily increasing. However, the recurrent side effects of cancer and its treatment can result in multiple disabilities and disruptions to day-to-day life, including work disruptions. Despite the existing knowledge of best practices regarding return to work (RTW) for breast cancer survivors, only a few interdisciplinary interventions have been developed to address the individualized needs and multiple challenges of breast cancer survivors, health care professionals, and employer and insurer representatives. Thus, it seems appropriate to develop RTW interventions collaboratively by using a co-design approach with these specific stakeholders.

objectiveThis paper presents a protocol for developing and testing an innovative, interdisciplinary pilot intervention based on a co-design approach to better support RTW and job retention after breast cancer treatment.

methodsFirst, a participatory research approach will be used to develop the intervention in a co-design workshop with 12 to 20 participants, including people affected by cancer, employer and insurer representatives, and health care professionals. Next, a pilot intervention will be tested in a primary care setting with 6 to 8 women affected by breast cancer. The acceptability and feasibility of the pilot intervention will be pretested through semistructured interviews with participants, health care professionals, and involved patient partners. The transcribed data will undergo an iterative content analysis.

resultsThe first phase of the project-the co-design workshop-was completed in June 2021. The pilot test of the intervention will begin in spring 2022. The results from the test will be available in late 2022.

conclusionsThe project will offer novel data regarding the use of the co-design approach for the development of innovative, co-designed interventions. In addition, it will be possible to document the acceptability and feasibility of the pilot intervention with a primary care team. Depending on the results obtained, the intervention could be implemented on a larger scale. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/37009.

Indexed as

breast cancerco-designinterventionprimary carequalitativereturn-to-work

Identifiers

PMID35451972
PMCPMC9077508
OpenAlexW4220862721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.